Johnson & Johnson - 47 Year Dividend Yield History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1972. The current TTM dividend payout for Johnson & Johnson (JNJ) as of February 20, 2019 is $3.60. The current dividend yield for Johnson & Johnson as of February 20, 2019 is 2.65%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $364.043B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $253.592B 14.20
Merck (MRK) United States $213.646B 18.26
Novartis AG (NVS) Switzerland $207.831B 17.68
Eli Lilly (LLY) United States $129.375B 21.97
Novo Nordisk (NVO) Denmark $122.958B 19.89
AbbVie (ABBV) United States $121.119B 10.18
Sanofi (SNY) France $105.891B 13.07
AstraZeneca (AZN) United Kingdom $102.481B 11.69
GlaxoSmithKline (GSK) United Kingdom $102.424B 13.45
Bristol-Myers Squibb (BMY) United States $83.830B 12.90